Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells

被引:2
|
作者
Yalcintepe, Leman [1 ]
Erdag, Demet [1 ]
Akbas, Fahri [2 ]
Kucukkaya, Bahire [3 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Biophys, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey
[3] Istanbul Yeni Yuzyil Univ, Fac Med, Dept Biophys, Istanbul, Turkey
关键词
doxorubicin; drug resistance; intracellular calcium; iron; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MULTIDRUG-RESISTANCE; INTRACELLULAR CALCIUM; MOLECULAR-MECHANISMS; NA+/CA2+ EXCHANGERS; THERAPY RESISTANCE; P-GLYCOPROTEIN; CANCER; SENSITIVITY; METABOLISM;
D O I
10.1111/1440-1681.13295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Iron is an essential trace element especially in cell proliferation, and growth for various cellular events. An increasing amount of research has shown that iron metabolism is altered in tumour cells which usually have rapid growth rates. However, the number of studies on iron metabolism, and calcium regulation are limited in drug-resistant tumour cells. Previously, we have shown that modulation of iron metabolism through iron chelation regulated the intracellular calcium, and increased the doxorubicin sensitivity. In the present study, we investigated the effects of iron on mRNA expression profiles of fifteen key genes (IP(3)R1/2/3, RYR1/2, SERCA1/2/3, NCX1/2/3, PMCA1/2/3, and PMCA4) related to calcium homeostasis in the parental cell line K562 and its subclone doxorubicin-resistant K562 cells. According to the Delta Delta Ct method with a two-fold expression difference (P < .05) as a cut-off level, although iron showed differential effects on most of the genes, IP3R and PMCA genes were especially determined to have changed significantly. These results show that iron metabolism is an important metabolism due to changes in the expression of genes involved in calcium regulation and is a new perspective to overcome cancer/drug resistance.
引用
收藏
页码:1221 / 1230
页数:10
相关论文
共 50 条
  • [41] Overexpression of the mitochondrial Ca2+ uniporter in cones alters Ca2+ and mitochondrial homeostasis
    Hutto, Rachel
    Bisbach, Celia M.
    Hurley, James
    Brockerhoff, Susan E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [42] Ionic currents in multidrug resistant K562 human leukemic cells
    Assef, YA
    Cavarra, SM
    Damiano, AE
    Ibarra, C
    Kotsias, BA
    LEUKEMIA RESEARCH, 2005, 29 (09) : 1039 - 1047
  • [43] Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine
    Clary, A
    Larrue, A
    Pourquier, P
    Robert, J
    ANTI-CANCER DRUGS, 1998, 9 (03) : 245 - 254
  • [44] Establishment and molecular characterization of decitabine-resistant K562 cells
    Wen, Xiang-Mei
    Zhang, Ting-Juan
    Ma, Ji-Chun
    Zhou, Jing-Dong
    Xu, Zi-Jun
    Zhu, Xiao-Wen
    Yuan, Qian
    Ji, Run-Bi
    Chen, Qin
    Deng, Zhao-Qun
    Lin, Jiang
    Qian, Jun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (05) : 3317 - 3324
  • [45] Comparison of antileukemic immunity mediated by dendritic cells derived from multidrug resistant leukemia K562/A02 cells and sensitive K562 cells
    Zhang, YM
    Zhang, LS
    Zhang, YF
    Chai, Y
    Yi, LC
    Song, FX
    CHINESE MEDICAL JOURNAL, 2005, 118 (07) : 595 - 597
  • [46] Low-dose radiation-induced cell death in doxorubicin-sensitive leukemic K562 and resistant leukemic K562/Dox cancer cells associated with ferroptosis induction
    Wattanapongpitak, Sakornniya
    Kothan, Suchart
    Tima, Singkome
    Tungjai, Montree
    TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES, 2023, 15 (03) : 249 - 255
  • [48] Comparison of antileukemic immunity mediated by dendritic cells derived from multidrug resistant leukemia K562/A02 cells and sensitive K562 cells
    ZHANG Yanming ZHANG Liansheng ZHANG Yufang CHAI Ye YI Liangcai and SONG FeixueDepartment of Hematology and Oncology Second Hospital of Lanzhou University Lanzhou China
    Chinese Medical Journal, 2005, (07) : 595 - 597
  • [49] ROLE OF THE ACLACINOMYCIN-A - DOXORUBICIN ASSOCIATION IN REVERSAL OF DOXORUBICIN RESISTANCE IN K562 TUMOR-CELLS
    MILLOT, JM
    RASOANAIVO, TDW
    MORJANI, H
    MANFAIT, M
    BRITISH JOURNAL OF CANCER, 1989, 60 (05) : 678 - 684
  • [50] Low-dose radiation-induced cell death in doxorubicin-sensitive leukemic K562 and resistant leukemic K562/Dox cancer cells associated with ferroptosis induction
    Sakornniya Wattanapongpitak
    Suchart Kothan
    Singkome Tima
    Montree Tungjai
    Toxicology and Environmental Health Sciences, 2023, 15 : 249 - 255